Clinical trial
APDM Instrumented Data Exchange for Ataxia (IDEA) Study
NCT04268147 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- APDM Instrumented Data Exchange for Ataxia (IDEA) Study
- Lead sponsor
- University of Chicago
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2019
- Completion date
- June 30, 2024
- Enrollment
- 128 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
friedreich ataxia, spinocerebellar ataxia type 1, spinocerebellar ataxia type 2, spinocerebellar ataxia type 3, spinocerebellar ataxia type 6